Learn more about whether Natera, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on AAII's A+ ...
In a report released today, Greg Harrison from Scotiabank maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...
Vertex Pharmaceuticals, Inc. is a global biotechnology ... Boger in 1989 and is headquartered in Boston, MA.
Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer ...
Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug ...
Vertex Pharmaceuticals Inc. will work with a Watertown biotech on new gene-editing therapies for people with sickle cell disease and transfusion-dependent beta thalassemia. A Watertown biotech is ...
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares are trading higher Friday following two major developments that strengthen ...
Investor's Business Daily on MSN1d
How Painkillers Could Be Vertex Pharmaceuticals' Next $10 Billion ChapterVertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped.
Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vertex Inc ... Pharmaceuticals, Vertex is a company specializing in consulting services and tax preparation software. S&P 500 components Fortinet and Boston ...
Shares of Vertex Pharmaceuticals Inc. VRTX inched 0.72% higher to $408.18 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX ...
Moderna, Inc.; Entrada Therapeutics ... duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback